Table 2.
Frequency distribution of the 10-year risk score categories for atherosclerotic cardiovascular disease among postmenopausal women with different oral glucose tolerance status.
| NGT | IGT | IPH* | IPH† | |
|---|---|---|---|---|
| 10-year ASCVD risk score | ||||
| <5% | 121 (89.0) | 171 (79.9) | 53 (67.9) | 22 (28.2) |
| 5%–7.4% | 11 (8.1) | 23 (10.7) | 14 (17.9) | 20 (25.6) |
| ≥7.5% | 4 (2.9) | 20 (9.3) | 11 (14.1) | 36 (46.2) |
Data are expressed as subject number (%).
ASCVD = atherosclerotic cardiovascular disease, IGT = impaired glucose tolerance, IPH = isolated postchallenge hyperglycemia, NGT = normal glucose tolerance.
Subjects with IPH were not designated as patients of diabetes mellitus while performing ASCVD risk estimation (scenario 1).
Subjects with IPH were designated as patients of diabetes mellitus while performing ASCVD risk estimation (scenario 2).